CW July 2005
Volume 14Issue Number 7 July 2005 ISSN 10593802 Novel Therapy Helps Some MDS Patients Avoid Blood TransfusionsLenalidomide, an oral drug similar in structure to thalidomide, is highly active for myelodysplastic disease patients with a deletion of chromosome 5q31, and is the first effective therapy for this specific subtype of disease.
Go to Previous Page Go to Next Page Source & Additional Reading A. List, 41st Annual Meeting of the American Society of Clinical Oncology. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW July 2005Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
